Novel Nanotechnology Approaches to Overcome Drug Resistance in the Treatment of Hepatocellular Carcinoma: Glypican 3 as a Useful Target for Innovative Therapies

Hepatocellular carcinoma (HCC) is the second most lethal tumor, with a 5-year survival rate of 18%. Early stage HCC is potentially treatable by therapies with curative intent, whereas chemoembolization/radioembolization and systemic therapies are the only therapeutic options for intermediate or adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Mossenta, Monica, Busato, Davide, Dal Bo, Michele, Macor, Paolo, Toffoli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456072/
https://www.ncbi.nlm.nih.gov/pubmed/36077433
http://dx.doi.org/10.3390/ijms231710038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456072/
https://www.ncbi.nlm.nih.gov/pubmed/36077433
http://dx.doi.org/10.3390/ijms231710038

Ejemplares similares